ALK/EGFR-IN-3 is a potent dual inhibitor of ALK and EGFR tyrosine kinases. It exhibits strong anti-proliferative activity in vitro against cancer cell lines such as H1975, PC9, and BaF3-EML4-ALK. This compound is a valuable research tool for studying targeted therapies in non-small cell lung cancer models.